Predicting severity of COPD flare-ups
Part of Lungs & breathing clinical trials.
This study uses a model to predict how severe a COPD flare-up (AECOPD) will be, combining Western and traditional Chinese medicine information. It could help doctors choose the right treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a COPD flare-up (AECOPD).
- You are willing to take part in the study and sign a consent form.
- You do not have a severe mental illness or thinking problems that would prevent you from communicating normally.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a Chinese medicine treatment can help people who are in the hospital for a very bad COPD flare-up. It aims to see if it can improve breathing and recovery.
This study looks at whether simple blood tests (red blood cells and platelets) can help predict how well patients recover from a COPD flare-up. It may help doctors plan better care.
This study looks at factors that can predict when chronic obstructive pulmonary disease (COPD) will flare up. It may help doctors identify people at higher risk sooner and tailor care to prevent flare-ups.
This study builds a tool to predict which COPD patients are likely to have worsening symptoms. It may help your doctor better manage your care if you have severe COPD.
This study looks at people hospitalized for a COPD flare-up (“exacerbation”). It may help improve how flare-ups are treated because participants need to receive the usual rescue medicines like steroids and/or antibiotics and then follow a study plan.
This study tests whether a wearable device and a smartphone app can predict when your COPD will flare up. It uses AI to spot early warning signs, so you might get help sooner.
Hear when a new Acute Exacerbation of Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.